CYTEK BIOSCIENCES INC

Cytek Biosciences Reports First Quarter 2025 Financial Results

08 May 2025 13:05:01 By Nasdaq GlobeNewswire

Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025

29 Apr 2025 14:00:00 By Nasdaq GlobeNewswire

Cytek Biosciences to Report First Quarter 2025 Financial Results on May 8, 2025

24 Apr 2025 13:05:00 By Nasdaq GlobeNewswire

Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System

18 Mar 2025 14:00:00 By Nasdaq GlobeNewswire

Cytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook

27 Feb 2025 13:05:01 By Nasdaq GlobeNewswire

Cytek Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

13 Feb 2025 13:05:00 By Nasdaq GlobeNewswire

Cytek Biosciences to Participate in Upcoming Investor Conferences

05 Feb 2025 13:05:00 By Nasdaq GlobeNewswire

Cytek Biosciences Announces Preliminary Full Year 2024 Revenue Results

15 Jan 2025 05:00:00 By Nasdaq GlobeNewswire

Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare Conference

02 Jan 2025 05:00:00 By Nasdaq GlobeNewswire

Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025

30 Dec 2024 05:00:00 By Nasdaq GlobeNewswire

Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare Conference

20 Nov 2024 13:05:00 By Nasdaq GlobeNewswire

Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program

19 Nov 2024 14:00:00 By Nasdaq GlobeNewswire

Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter

07 Nov 2024 14:00:00 By Nasdaq GlobeNewswire

Cytek Biosciences Reports Third Quarter 2024 Financial Results

05 Nov 2024 13:05:00 By Nasdaq GlobeNewswire

Cytek Biosciences to Participate in Upcoming Investor Conferences

30 Oct 2024 13:05:00 By Nasdaq GlobeNewswire

Cytek Biosciences to Report Third Quarter 2024 Financial Results on November 5, 2024

29 Oct 2024 13:05:00 By Nasdaq GlobeNewswire

Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe

18 Sep 2024 14:00:00 By Nasdaq GlobeNewswire

Cytek Announces Resignation of Chief Operating Officer Chris Williams

12 Sep 2024 12:20:00 By Nasdaq GlobeNewswire

Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility

21 Aug 2024 14:00:00 By Nasdaq GlobeNewswire

Cytek Biosciences to Participate in Upcoming Investor Conferences

08 Aug 2024 13:05:01 By Nasdaq GlobeNewswire